Key stats
About Penghua CSI Traditional Chinese Medicine ETF
Home page
Inception date
Jul 20, 2022
Structure
Open-Ended Fund
Replication method
Physical
Dividend treatment
Distributes
Primary advisor
Penghua Fund Management Co., Ltd.
ISIN
CNE100005J70
Tightly track the target index, and pursue the minimization of tracking deviation and tracking err. The Fund strives to control the daily average tracking deviation within 0.2% , and the annual tracking err within 2% .
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks97.80%
Health Technology97.80%
Bonds, Cash & Other2.20%
Cash2.20%
Stock breakdown by region
Asia100.00%
North America0.00%
Latin America0.00%
Europe0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
159647 top holdings are Yunnan Baiyao Group Co. Ltd. Class A and Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Class A, occupying 10.47% and 9.64% of the portfolio correspondingly.
No, 159647 doesn't pay dividends to its holders.
159647 shares are issued by Penghua Fund Management Co., Ltd. under the brand Penghua. The ETF was launched on Jul 20, 2022, and its management style is Passive.
159647 expense ratio is 0.60% meaning you'd have to pay 0.60% of your investment to help manage the fund.
159647 follows the CSI Traditional Chinese Medicine Index - CNY - Benchmark TR Gross. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
159647 invests in stocks.